Neuroendocrine Carcinoma of the Breast, NOS
Clinical
- Studies using thresholds of both <50% and >50% cellular reactivity for neuroendocrine markers have found no independent clinical significance in carcinomas with conventional patterns
- Prognosis appears to be driven by grade in such cases
